https://www.selleckchem.com/pr....oducts/penicillin-st
Results show that the use of an imperfect assay affects the operational characteristics of the Bayesian biomarker-based outcome-adaptive randomization design. In particular, the misclassification causes a substantial reduction in power accompanied by a considerable increase in the type-I error probability. The magnitude of these effects depends on the sensitivity and specificity of the assay, as well as on the distribution of the biomarker in the patient population. With an imperfect biomarker assay, the decision to appl
Curtir
Comentario
Compartilhar
